330 related articles for article (PubMed ID: 25843815)
21. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
22. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.
Anwar F; Mahmood E; Sharif S; Shah R; Jamgochian M; Ouellette S; Umar M; Rao B
J Drugs Dermatol; 2023 Jun; 22(6):594-598. PubMed ID: 37276157
[TBL] [Abstract][Full Text] [Related]
23. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
24. Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas.
Dalla Costa R; Prindaville B; Wiss K
Pediatr Dermatol; 2018 Mar; 35(2):276-277. PubMed ID: 29315812
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Gong H; Xu DP; Li YX; Cheng C; Li G; Wang XK
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):836-40. PubMed ID: 26427968
[TBL] [Abstract][Full Text] [Related]
26. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
He L; Huang G
J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
[TBL] [Abstract][Full Text] [Related]
27. Topical timolol gel for infantile hemangiomas: a pilot study.
Pope E; Chakkittakandiyil A
Arch Dermatol; 2010 May; 146(5):564-5. PubMed ID: 20479314
[No Abstract] [Full Text] [Related]
28. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
Sorrell J; Chamlin SL
Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
[TBL] [Abstract][Full Text] [Related]
29. Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection.
Zhang JY; Lan SJ; Liu M; Yang TY; Liu SS; Rong L
J Craniofac Surg; 2021 May; 32(3):988-990. PubMed ID: 33538448
[TBL] [Abstract][Full Text] [Related]
30. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
31. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
[TBL] [Abstract][Full Text] [Related]
32. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study].
Ye XX; Jin YB; Lin XX; Ma G; Chen XD; Qiu YJ; Chen H; Hu XJ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):161-4. PubMed ID: 22870699
[TBL] [Abstract][Full Text] [Related]
33. β-blockers for infantile hemangiomas: a single-institution experience.
Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
[TBL] [Abstract][Full Text] [Related]
34. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.
Wu HW; Liu C; Wang X; Zhang L; Yuan W; Zheng JW; Su LX; Fan XD
Front Oncol; 2017; 7():137. PubMed ID: 28702374
[TBL] [Abstract][Full Text] [Related]
35. Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas.
Choo W
Int J Pharm Compd; 2017; 21(4):282-289. PubMed ID: 28719370
[TBL] [Abstract][Full Text] [Related]
36. Fractional 2940-nm Er:YAG laser-assisted drug delivery of timolol maleate for the treatment of deep infantile hemangioma.
Sun L; Wang C; Cao Y; Lv X; Tian L; Liu D; Li L; Zhao W
J Dermatolog Treat; 2021 Dec; 32(8):1053-1059. PubMed ID: 32043380
[TBL] [Abstract][Full Text] [Related]
37. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study.
Semkova K; Kazandjieva J
Clin Exp Dermatol; 2013 Mar; 38(2):143-6. PubMed ID: 22731954
[TBL] [Abstract][Full Text] [Related]
38. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Hu L; Huang HZ; Li X; Lin XX; Li W
Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Introduction Timolol Maleate by Manometer Microneedles among Infantile Hemangioma: A Retrospective Study in China.
Yuan L; Wang J
Eur J Pediatr Surg; 2024 Jun; 34(3):261-266. PubMed ID: 37127023
[TBL] [Abstract][Full Text] [Related]
40. The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.
Khan M; Boyce A; Prieto-Merino D; Svensson Å; Wedgeworth E; Flohr C
Acta Derm Venereol; 2017 Nov; 97(10):1167-1171. PubMed ID: 28421234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]